Gsa Capital Partners LLP Optimize Rx Corp Transaction History

Gsa Capital Partners LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	BUY	$7.43 - $14.96 $13,492 - $27,167	1,816 Added 2.91%	64,143 $499,000
Q2 2023 Aug 14, 2023	BUY	$11.63 - $15.63 $86,887 - $116,771	7,471 Added 13.62%	62,327 $890,000
Q1 2023 May 12, 2023	BUY	$12.54 - $19.38 $307,443 - $475,139	24,517 Added 80.81%	54,856 $802,000
Q4 2022 Feb 13, 2023	SELL	$13.77 - $22.04 $275,193 - $440,469	-19,985 Reduced 39.71%	30,339 $510,000
Q3 2022 Nov 14, 2022	BUY	$13.74 - $30.13 $691,451 - $1.52 Million	50,324 New	50,324 $746,000
Q4 2020 Feb 03, 2021	SELL	$19.04 - $33.1 $294,758 - $512,421	-15,481 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$12.99 - $21.78 $201,098 - $337,176	15,481 New	15,481 $323,000

13.3M

79.8K

41.4K

Ticker OPRX
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 18,023,100
Market Cap $140M
Description
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patien...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.